非侵入性顱內壓監測設備市場－全球產業規模、佔有率、趨勢、機會和預測（按類型、應用、地區和競爭細分，2020-2030 年）

2024 年全球非侵入性顱內壓 (ICP) 監測設備市值為 3.5123 億美元，預計到 2030 年將達到 4.8306 億美元，預測期內複合年成長率為 5.43%。由於需要定期監測顱內壓的神經系統疾病和創傷性腦損傷 (TBI) 的盛行率不斷上升，市場發展也越來越受到關注。非侵入性 ICP 監測設備提供了一種比傳統方法更安全、侵入性更小的替代方法，可顯著降低感染和患者不適等風險。它們在急診、門診和重症監護環境中的易用性支持了其日益普及的採用。

正在進行的技術創新，包括使用經顱多普勒的設備、基於眼睛的技術和成像整合，正在提高診斷的準確性和臨床效率。人工智慧在解釋 ICP資料的作用日益增強，進一步簡化了護理並支持併發症的早期發現。緊湊、便攜的型號可以在遠端和床邊進行監控，擴大臨床實用性。此外，人們對兒科和穿戴式應用的興趣正在不斷擴大，將非侵入性 ICP 設備定位為現代神經護理的重要工具。

關鍵市場促進因素

創傷性腦損傷（TBI）和神經系統疾病發生率上升

主要市場挑戰

缺乏標準化和臨床驗證

主要市場趨勢

兒科和重症監護中的非侵入性監測

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球無創顱內壓監測設備市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依類型（經顱多普勒超音波檢查、鼓膜位移 (TMD)、視神經鞘直徑、MRI/CT、其他）
  • 依應用（腦外傷、腦出血、腦膜炎、蜘蛛膜下腔出血、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第6章：北美無創顱內壓監測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲非侵入性顱內壓監測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區非侵入性顱內壓監測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲無創顱內壓監測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲無創顱內壓監測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Medtronic plc
• Raumedic AG
• Integra LifeSciences Holdings Corporation
• Spiegelberg GmbH & Co. KG
• Natus Medical Incorporated
• Siemens Healthineers AG
• Sophysa SA
• NeuroWave Systems Inc.
• HeadSense Medical Ltd.
• BrainScope Company, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

The Global Non-invasive Intracranial Pressure (ICP) Monitoring Devices Market was valued at USD 351.23 Million in 2024 and is projected to reach USD 483.06 Million by 2030, growing at a CAGR of 5.43% during the forecast period. The market is gaining traction due to the increasing prevalence of neurological conditions and traumatic brain injuries (TBIs) that require regular intracranial pressure monitoring. Non-invasive ICP monitoring devices offer a safer, less intrusive alternative to traditional methods, significantly reducing risks such as infections and patient discomfort. Their ease of use across emergency, outpatient, and critical care environments supports their rising adoption.

Ongoing technological innovations, including devices using transcranial Doppler, ocular-based techniques, and imaging integration, are enhancing diagnostic accuracy and clinical efficiency. The growing role of artificial intelligence in interpreting ICP data is further streamlining care and supporting early detection of complications. Compact, portable models are enabling monitoring in remote and bedside settings, broadening clinical utility. Additionally, interest is expanding in pediatric and wearable applications, positioning non-invasive ICP devices as essential tools in modern neurological care.

Key Market Drivers

Rising Incidence of Traumatic Brain Injuries (TBIs) and Neurological Disorders

The increasing prevalence of TBIs and neurological disorders is a significant factor propelling demand for non-invasive ICP monitoring devices. TBIs, often resulting from falls, accidents, and sports-related injuries, require constant pressure surveillance to avoid secondary brain damage. Non-invasive ICP devices offer a risk-free alternative for such monitoring, ensuring better patient outcomes.

Moreover, neurological disorders such as stroke, epilepsy, and dementia contribute to elevated intracranial pressure and are on the rise globally. For example, dementia affects around 55 million people worldwide, with 10 million new cases each year, while epilepsy impacts approximately 50 million individuals globally. These conditions underscore the clinical importance of safe and accurate ICP monitoring.

Healthcare providers are increasingly integrating non-invasive technologies to improve diagnostic efficiency and patient safety, driving market growth as neurological disease rates continue to climb across all age groups.

Key Market Challenges

Lack of Standardization and Clinical Validation

A key limitation to wider adoption of non-invasive ICP monitoring technologies is the absence of standardized protocols and sufficient clinical validation. Current devices often operate using varied techniques without a unified calibration framework, making it difficult to compare results across different healthcare settings or devices. This variability affects clinician confidence and limits the integration of such tools in high-acuity environments like ICUs.

Furthermore, many non-invasive solutions lack broad-based clinical validation across diverse patient populations, limiting their acceptance among medical professionals. Until these technologies demonstrate consistent reliability and undergo rigorous trials, market penetration may remain constrained, especially in regions with strict regulatory standards and clinical governance frameworks.

Key Market Trends

Non-invasive Monitoring in Pediatrics and Critical Care

The increasing demand for non-invasive ICP monitoring in pediatric and critical care units marks a prominent trend in the market. These patient populations are particularly vulnerable to the risks associated with invasive techniques. In pediatrics, non-invasive methods offer a safer, less traumatic approach for diagnosing conditions linked to elevated ICP.

In critical care, continuous monitoring without the risks of hemorrhage or infection is essential. Non-invasive systems enable round-the-clock surveillance without physically breaching the skull, making them valuable in ICUs and emergency departments. Enhanced device portability and real-time data collection are further enabling widespread clinical use in sensitive care environments.

This trend aligns with the global healthcare focus on minimally invasive, patient-centric technologies, supporting broader integration of non-invasive ICP devices in acute and long-term care protocols.

Key Market Players

• Medtronic plc
• Raumedic AG
• Integra LifeSciences Holdings Corporation
• Spiegelberg GmbH & Co. KG
• Natus Medical Incorporated
• Siemens Healthineers AG
• Sophysa SA
• NeuroWave Systems Inc.
• HeadSense Medical Ltd.
• BrainScope Company, Inc.

Report Scope

In this report, the Global Non-invasive Intracranial Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-invasive Intracranial Pressure Monitoring Devices Market, By Type:

• Transcranial Doppler Ultrasonography
• Tympanic Membrane Displacement (TMD)
• Optic Nerve Sheath Diameter
• MRI/CT
• Others

Non-invasive Intracranial Pressure Monitoring Devices Market, By Application:

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Subarachnoid Hemorrhage
• Others

Non-invasive Intracranial Pressure Monitoring Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-invasive Intracranial Pressure Monitoring Devices Market.

Available Customizations

Global Non-invasive Intracranial Pressure Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Transcranial Doppler Ultrasonography, Tympanic Membrane Displacement (TMD), Optic Nerve Sheath Diameter, MRI/CT, Others)
  • 5.2.2. By Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Medtronic plc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Raumedic AG
• 14.3. Integra LifeSciences Holdings Corporation
• 14.4. Spiegelberg GmbH & Co. KG
• 14.5. Natus Medical Incorporated
• 14.6. Siemens Healthineers AG
• 14.7. Sophysa SA
• 14.8. NeuroWave Systems Inc.
• 14.9. HeadSense Medical Ltd.
• 14.10. BrainScope Company, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer